163 participants
Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-12
- Start Date:
- 2012-12-20
- Completion:
- 2015-11-26
Conditions
- Chronic Myeloid Leukemia
Interventions
- DRUG